2nd Quarter - Report
GOLDBUG STRATEGIES LLC for 23ANDME, INC.
Client
Income
$30,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 15, 2016 | $30,000 | Replaced |
| 2nd Quarter - Report (this page) | Jul 15, 2016 | $30,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHEILA D WALCOFF | 2006-07 Counselor to HHS Secretary Michael O. Leavitt (Immed |
Health Issues HCR
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHEILA D WALCOFF | 2006-07 Counselor to HHS Secretary Michael O. Leavitt (Immed |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.